SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000898430-99-003073
Filing Date
1999-08-03
Accepted
1999-08-03 00:00:00
Documents
9
Period of Report
1999-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 88256
2 AMENDED AND RESTATED BYLAWS OF AMGEN (JUNE 29, 1999) EX-3.2 67374
3 RESTATED CERTIFICATE OF INCORPORATION EX-3.3 2836
4 CERTIFICATE OF DESIGNATION EX-3.4 2457
5 AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN EX-10.1 48370
6 PERFORMANCE BASED MANAGEMENT INCENTIVE PLAN EX-10.20 22021
7 SEVENTH AMEND TO THE AMGEN RETIREMENT AND SAVINGS EX-10.26 6129
8 FINANCIAL DATA SCHEDULE EX-27 2486
9 FACTORS THAT MAY AFFECT AMGEN EX-99 12367
  Complete submission text file 0000898430-99-003073.txt   254757
Mailing Address 1840 DEHAVILLAND DR. MAIL STOP 10-1-B-512 THOUSAND OAKS CA 91320-1789
Business Address 1840 DEHAVILLAND DR THOUSAND OAKS CA 91320-1789 0854471000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 99677079
SIC: 2836 Biological Products, (No Diagnostic Substances)